< Back to latest news & events

Knowledge Hub

No Official Fee to Opt Out of the UPC

February 2016

The Preparatory Committee for the UPC has agreed the Rules on Court fees and recoverable costs for the UPC. The biggest change, and welcome news for proprietors of existing EP patents and applications is that no fee will be payable in order to opt out of the jurisdiction of the UPC. Many have lobbied that this should have always been the case, and will welcome this news.

The Preparatory Committee had made a commitment that the fees for both the opt-out and its withdrawal would be set to reclaim administrative costs only and that the UPC would not profit from either of these. Recognising that the administration burden of opting out rests almost entirely with the applicant and also that any cost to the Court associated with the opt-out is related to processing the fee, the fee has been removed in the final agreed version of the UPC fees here.

Court fees have also now been set, with the maximum ceiling for recoverable costs for proceedings with values of more than €50 million being capped at €2 million. The provisions for seeking reductions have been set at reimbursement, wholly or partially, of and fixed and value-based fee. Interesting the “test” for who can apply for a reimbursement remains the same; it has been speculated that non-practising entities could benefit from this arrangement.

This update was prepared by Martyn Fish, Partner in our Leeds office. If you would like further advice on this or any other matter please contact Martyn or your usual HGF representative or visit our Contact page to get in touch with your nearest HGF office.

Latest updates

Often Copied, Never Equaled: When Do Everyday Items Become Subject of Copyright?

The  borderline between ‘pure’ works of art and mere utilitarian objects” –  Can iconic, yet everyday products be protected under copyright? The above question was posed by Advocate General in …

Read article

T 0883/23: Dosage claims and their entitlement to priority when only the clinical trial protocol was disclosed in the priority application

In a recently issued decision by the EPO’s Board of Appeal (BoA), the BoA held that claims directed to a combination of active pharmaceutical ingredients (APIs) at particular doses were …

Read article

The end of the Brexit overhang for trade marks: review, refile and revoke.

On the 31st December 2025, five years will have passed since the end of the Brexit transitional period on 31st December 2020. Why is this relevant? For UK cloned trade …

Read article
Event - 14th January 2026

Seminar on The aftermath of G1/24 - has anything changed?

HGF is hosting a The aftermath of G1/24 – has anything changed? Which will be followed by networking, apero, and snacks. The Seminar will be held on Wednesday, 14th January …

Event details

Personal names as 'brands' in the world of fashion

Episode 1 Personal names as ‘brands’ in the world of fashion    

Read article

Colour in fashion and the difficulties of protecting it

Episode 2 Colour in fashion and the difficulties of protecting it  

Read article

Trade marks which are fashion products, and fashion products which are trade marks

Episode 3 Trade marks which are fashion products, and fashion products which are trade marks

Read article

Zombie Fashion Brands

Episode 4 Zombie Fashion Brands  

Read article